The goals of this proposal are to determine whether the airway response to inhaled endotoxin is a genetically based trait in humans and to assess to what extent the expression of this trait is influenced by gender. Occupational and environmental exposure to grain dust can cause asthma and bronchitis. Endotoxin appears to be one of the primary components of grain dust (and other organic dusts) that causes airway inflammation and airflow obstruction. Lipopolysaccharide (LPS) is a specific type of endotoxin found in the cell wall of gram-negative bacteria. In a murine model, we have confirmed that LPS resistance is determined by a single gene (Lps response gene), and we have localized this gene to a 220,000 base pair region on chromosome 4. In preliminary human studies, we have shown that most health, non-asthmatic, non-apoptotic, life-timer non-cigarette smoking volunteers develop airflow obstruction with challenged with increasing concentrations of inhaled LPS. However, approximately 10% of subjects developed marked airflow obstruction after inhaling trivial amounts of LPS and 15% of subjects appear to be hyporesponsive after inhaling over 40 micrograms of LPS. In addition, females demonstrate greater bronchial sensitivity to inhaled LPS than males. These results lead us to hypothesize that the airway response to inhaled LPS is a genetically determined complex trait in humans. Moreover, gender appears to substantially influence the airway response to inhaled LPS. We will use a familial cohort design to determine whether the airway response to inhaled endotoxin is a genetically based trait in humans, and to assess to what extent the expression of this trait is influence by gender. The study design is dependent on two interactive stages. In the first stage, we will screen a relatively large population of healthy, unrelated volunteers (n=200) with incremental doses of inhaled LPS. This will allow us to identify approximately 50 study subjects who will serve as """"""""sensitive"""""""" or """"""""hyporesponsive"""""""" probands. These sensitive and hyporesponsive probands will be used to identify families for the second stage of this investigation. In the second stage of the study, we will evaluate the airway response to incremental doses of inhaled LPS among 100 first degree relatives of up to 50 sensitive and hyporesponsive probands. Finds from this study will help us to determine why only a small portion of workers develop airway disease when exposed to organic dust.
Whitehead, Gregory S; Walker, Julia K L; Berman, Katherine G et al. (2003) Allergen-induced airway disease is mouse strain dependent. Am J Physiol Lung Cell Mol Physiol 285:L32-42 |
Lorenz, Eva; Patel, Dhavalkumar D; Hartung, Thomas et al. (2002) Toll-like receptor 4 (TLR4)-deficient murine macrophage cell line as an in vitro assay system to show TLR4-independent signaling of Bacteroides fragilis lipopolysaccharide. Infect Immun 70:4892-6 |
Schwartz, David A (2002) TLR4 and LPS hyporesponsiveness in humans. Int J Hyg Environ Health 205:221-7 |
Schwartz, David A (2002) The genetics of innate immunity. Chest 121:62S-68S |
Lorenz, Eva; Mira, Jean Paul; Frees, Kathy L et al. (2002) Relevance of mutations in the TLR4 receptor in patients with gram-negative septic shock. Arch Intern Med 162:1028-32 |
Moreland, Jessica G; Fuhrman, Robert M; Pruessner, Jonathan A et al. (2002) CD11b and intercellular adhesion molecule-1 are involved in pulmonary neutrophil recruitment in lipopolysaccharide-induced airway disease. Am J Respir Cell Mol Biol 27:474-80 |
Savov, Jordan D; Gavett, Stephen H; Brass, David M et al. (2002) Neutrophils play a critical role in development of LPS-induced airway disease. Am J Physiol Lung Cell Mol Physiol 283:L952-62 |
Kiechl, Stefan; Lorenz, Eva; Reindl, Markus et al. (2002) Toll-like receptor 4 polymorphisms and atherogenesis. N Engl J Med 347:185-92 |
Maddox, Lee; Schwartz, David A (2002) The pathophysiology of asthma. Annu Rev Med 53:477-98 |
Lorenz, E; Jones, M; Wohlford-Lenane, C et al. (2001) Genes other than TLR4 are involved in the response to inhaled LPS. Am J Physiol Lung Cell Mol Physiol 281:L1106-14 |
Showing the most recent 10 out of 18 publications